Zhejiang Huahai Pharmaceutical Co., Ltd.’s announcement on the results of the optional sell-back of “Huahai Convertible Bonds”
Stock abbreviation: Huahai Pharmaceutical Stock code: 600521 Announcement number: Lin 2025-134 Bond abbreviation: Huahai convertible bonds Bond code: 110076
Zhejiang Huahai Pharmaceutical Co., Ltd.
Announcement on the results of the optional sell-back of "Huahai Convertible Bonds"
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and bear individual and joint liability for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Sale-back period: December 22, 2025 to December 26, 2025
The number of valid declarations for sale back: 0 pieces
Sale-back amount: 0 yuan
No investors have applied for a sell-back during the buy-back declaration period. Therefore, the company does not need to handle follow-up business matters such as paying sell-back funds to investors. This sell-back has been completed.
1. Announcement of the sale of convertible bonds
Zhejiang Huahai Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") disclosed the "Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the optional sell-back of "Huahai Convertible Bonds"" on December 15, 2025 (Announcement No.: Lin 2025-121), and announced on December 16, 2025, December 17, 2025, and 2025 respectively. December 18, December 19, 2025, December 20, 2025, December 23, 2025, December 24, 2025, December 25, 2025, December 26, 2025 On the same day, an indicative announcement on the resale of "Huahai Convertible Bonds" was disclosed (announcement numbers are: Lin No. 2025-122, Lin 2025-124, Lin 2025-125, Lin 2025-126, Lin 2025-127, Lin 2025-128, Lin 2025-129 No., Lin No. 2025-130, Lin No. 2025-131). For details, please refer to the company’s relevant announcements published on China Securities Journal, Shanghai Securities News, Securities Times, Securities Daily and the Shanghai Stock Exchange website (www.sse.com.cn).
The code of the "Huahai Convertible Bonds" sold back this time is "110076", and the sell-back price is RMB 100.30 per piece (including current interest and tax). The sell-back application period for "Huahai Convertible Bonds" is from December 22, 2025 to December 26, 2025, and the sale-back application ended after the Shanghai Stock Exchange closed on December 26, 2025.
2. The results of this convertible bond sale and the impact of this sale on the company
(1) Result of sale back
The resale declaration period for "Huahai Convertible Bonds" is from December 22, 2025 to December 26, 2025, and the resale price is RMB 100.30 per piece (including current interest and tax). According to data provided by the Shanghai Branch of China Securities Depository and Clearing Co., Ltd., during the repurchase declaration period, the number of valid resale applications was 0, and the resale amount was RMB 0. The company does not need to handle follow-up business matters such as paying resale funds to investors. This resale has been completed.
(2) Impact of sale back
The sale back of "Huahai Convertible Bonds" will not have an impact on the company's cash flow, asset status, equity situation, etc.
3. Follow-up matters of this convertible bond sale
According to relevant regulations, the company's "Huahai Convertible Bonds" that have not been sold back will continue to be traded on the Shanghai Stock Exchange.
Announcement is hereby made.
Board of Directors of Zhejiang Huahai Pharmaceutical Co., Ltd.
December 30, 2025